Light
But this won’t be the vaccine that you and I get due to some rather problematic handling requirements:
From the BBC:
“There are also massive manufacturing and logistical challenges in immunising huge numbers of people, as the vaccine has to be kept in ultra-cold storage at below minus 80C.”
(
wheresthefish Partly filled with wrong, Mon 9 Nov 2020, 19:24,
Reply)
We can handle that
See freezer farms.
I mean, sure, it's a logistics thing.
Not a showstopper though.
It's fine.
The major concerns are;
a) Are there side-effects?
Probably nothing much, and so far, no. There's no reason to think there will be - but eh, caution. c/f thalidomide.
It was a relatively small trial, over a very short time.
b) Does it work for a long time?
We don't know. It was tested over a week.
Other similar vaccines tend to provide immunity for months or years; some need a "booster". We won't know that until months/years have passed.
(, Mon 9 Nov 2020, 20:31, Reply)
We *can* handle it
But it puts the cost per dose way up. This will get rolled out to the NHS and frontline services. The general population is far more likely to receive one of the other vaccines that will be far easier to handle.
(
wheresthefish Partly filled with wrong, Mon 9 Nov 2020, 20:52,
Reply)
